Materiały źródłowe

• #1 Microscopic Colitis | All you need to know | Gastro Health

  https://gastrohealth.com/news/patient-care/microscopic-colitis

  There is no evidence that microscopic colitis leads to an increase risk of colon cancer, as with ulcerative colitis. […] Management of microscopic colitis includes lifestyle changes aimed at reducing the diarrhea and discontinuing drugs like Nsaids and PPis. […] In many cases, treatment with antidiarrheal medications is necessary. Loperamide, Bismuth (Pepto Bismol), bulking agents like psyllium, or bile acid binding resins like cholestyramine are commonly used in the treatment of microscopic colitis. […] In more severe cases of diarrhea, corticosteroids can be used as treatment. Corticosteroids are medications that decrease inflammation and reduce the activity of the immune system. […] Therefore, this is the treatment of choice. […] Microscopic colitis is a chronic condition with symptoms that may come and go intermittently and cannot be diagnosed with blood tests or stool studies. […] In order to diagnose microscopic colitis, a physician must obtain a biopsy from the colon. […] In most cases, it can be easily treated and symptoms managed so patients can function normally.

• #2 Microscopic colitis – IBD Clinic

  https://ibdclinic.ca/what-is-ibd/microscopic-colitis/

  Microscopic Colitis is an inflammatory bowel disease that affects the large bowel (colon and rectum) and was first recognized by doctors 40 years ago. […] This web page provides a brief overview of Microscopic Colitis, including diagnosis, possible causes, and treatments. […] The main symptom of Microscopic Colitis is chronic (ongoing) watery diarrhea, which may begin very suddenly. […] If you are taking any of the drugs mentioned previously as possible triggers for Microscopic Colitis, then you may be asked to change or decrease the medication. […] If none of the steps mentioned above has improved your symptoms, you might need to take medication for your Microscopic Colitis. […] The main goal of treatment is to achieve clinical remission (freedom from symptoms) and improve the quality of life.

• #3 BATTLING MICROSCOPIC COLITIS: PROGNOSIS, TYPES, PREVENTION, AND TREATMENT | Mya Care

  https://myacare.com/blog/battling-microscopic-colitis-prognosis-types-prevention-and-treatment

  Microscopic colitis is classified as an inflammatory bowel disease (IBD) known to affect the colon or large intestine. Chronic watery diarrhea and colonic inflammation are the hallmark features of the condition. […] It is crucial to consult a doctor to receive suitable treatment and advice for managing the symptoms effectively. […] Despite the lack of a cure for microscopic colitis, treatments are available to manage the symptoms and improve quality of life. Treatment options include prophylactic prescription medication and dietary changes. […] Managing triggers is a critical aspect of preventing flares of microscopic colitis. […] Individuals with microscopic colitis can reduce the frequency and severity of flare-ups by identifying and avoiding these triggers. […] Working closely with a healthcare professional is highly recommended to manage your triggers and prevent symptoms.

• #4

  https://link.springer.com/article/10.1007/s40266-023-01094-6

  Microscopic colitis is a prevalent condition among older adults above the age of 60 years. […] Patients suspected with long-standing or recurrent non-bloody watery diarrhea should always be referred for colonoscopy with three biopsies from right and left colon followed by extensive histopathological evaluations. […] Oral budesonide is the drug of choice for microscopic colitis, but nonsteroidal medications, including bismuth subsalicylate, biologics, bile acid sequestrants, and supportive antidiarrheal drugs followed by thiopurines, may be useful alternatives. […] For the management of microscopic colitis, a treatment course with oral budesonide 9 mg/day for 68 weeks is considered first-line therapy. […] Accordingly, alternative therapeutics, including bismuth subsalicylate, biologics, bile acid sequestrants, and thiopurines, may be indicated to control the symptoms and enhance the quality of life of patients affected by this debilitating chronic disease, as recommended by international guidelines.

• #5 Microscopic Colitis: Dr. Falk Pharma international

  https://drfalkpharma.com/en/indications/microscopic-colitis/

  Microscopic colitis is a general term for two related conditions: lymphocytic colitis and collagenous colitis. Like Crohn’s disease and ulcerative colitis, it is an inflammatory bowel disease. […] Microscopic colitis is characterized by inflammation of the mucosal lining of the large intestine (colitis). […] Because this condition is accompanied by chronic inflammation of the intestines, it is classified as an inflammatory bowel disease (IBD) together with Crohn’s disease and ulcerative colitis. […] The exact cause of microscopic colitis remains unknown. […] Smoking is known to be a risk factor for developing microscopic colitis. […] The most important symptom of microscopic colitis is chronic, watery diarrhea that is often accompanied by upper abdominal pain, nausea, flatulence, fatigue, and some degree of weight loss.

• #6 Microscopic colitis – IBD Clinic

  https://ibdclinic.ca/what-is-ibd/microscopic-colitis/

  Microscopic Colitis is an inflammatory bowel disease that affects the large bowel (colon and rectum) and was first recognized by doctors 40 years ago. […] This web page provides a brief overview of Microscopic Colitis, including diagnosis, possible causes, and treatments. […] The main symptom of Microscopic Colitis is chronic (ongoing) watery diarrhea, which may begin very suddenly. […] If you are taking any of the drugs mentioned previously as possible triggers for Microscopic Colitis, then you may be asked to change or decrease the medication. […] If none of the steps mentioned above has improved your symptoms, you might need to take medication for your Microscopic Colitis. […] The main goal of treatment is to achieve clinical remission (freedom from symptoms) and improve the quality of life.

• #7 We Offer Microscopic Colitis Treatment in Colorado

  https://www.rockymountaingastro.com/services/microscopic-colitis/

  Receiving a medical diagnosis can be as relieving as it is daunting. […] If you’ve recently been diagnosed with microscopic colitis, Rocky Mountain Gastroenterology is here to help. […] Our Denver, CO specialists provide cutting-edge treatment for a wide range of conditions, including colitis. […] Microscopic colitis is a type of inflammation of the colon, or large intestine, that can cause persistent diarrhea and stomach pain. […] The condition is often grouped with other inflammatory bowel diseases and tends to affect older women more often than men. […] Knowing the most common microscopic colitis symptoms is crucial, as identifying your condition early means quicker relief. […] Let your doctor know if you have any of these symptoms: Persistent diarrhea, Watery stools, Bloating, Abdominal pain, Nausea, Fecal incontinence, Dehydration, Fatigue, Unexplained weight loss, Frequent bowel movements.

• #8 Microscopic Colitis: Symptoms, Causes, Treatment

  https://resources.healthgrades.com/right-care/digestive-health/microscopic-colitis

  Microscopic colitis is when atypical immune reactions cause inflammation in the colon. It is a less common type of inflammatory bowel disease (IBD). Symptoms include abdominal pain, diarrhea, cramps, weight loss, and nausea. […] This article discusses microscopic colitis, including its symptoms, causes, and treatments. […] Microscopic colitis is a type of inflammatory bowel disease (IBD) that doctors can only detect under a microscope. IBDs are chronic conditions characterized by inflammation in the intestines. […] Generally, microscopic colitis is non-life-threatening. However, it can irritate the intestinal lining, causing frequent watery diarrhea and dehydration. […] Many cases of microscopic colitis come and go and may intensify in response to certain triggers. […] The most common symptom of microscopic colitis is frequent watery diarrhea. Other symptoms include abdominal pain or cramps, dehydration, weight loss, stool urgency, nausea and bloating, and stool incontinence.

• #9 Microscopic colitis: a guide for general practice | British Journal of General Practice

  https://bjgp.org/content/71/702/41

  Microscopic colitis cannot be diagnosed in primary care. […] The initial treatment for most patients with microscopic colitis is oral budesonide at a dose of 9 mg/day for a period of 68 weeks; 81%84% of patients respond successfully to treatment compared with 36%43% given a placebo. […] Patients may enter and stay in remission at this point; however, some studies have shown that patients may need long-term budesonide (for at least 6 months) at 3 mg or 6 mg/day but this should be titrated according to clinical response. […] Prednisolone, loperamide, bismuth, mesalazine, antibiotics, or probiotics are not recommended treatments. […] A summary of the information on microscopic colitis is shown in Box 1. […] Treatment is with oral budesonide 9 mg/day for an initial period of 68 weeks.

• #10

  https://link.springer.com/article/10.1007/s40266-023-01094-6

  Microscopic colitis is a prevalent condition among older adults above the age of 60 years. […] Patients suspected with long-standing or recurrent non-bloody watery diarrhea should always be referred for colonoscopy with three biopsies from right and left colon followed by extensive histopathological evaluations. […] Oral budesonide is the drug of choice for microscopic colitis, but nonsteroidal medications, including bismuth subsalicylate, biologics, bile acid sequestrants, and supportive antidiarrheal drugs followed by thiopurines, may be useful alternatives. […] For the management of microscopic colitis, a treatment course with oral budesonide 9 mg/day for 68 weeks is considered first-line therapy. […] Accordingly, alternative therapeutics, including bismuth subsalicylate, biologics, bile acid sequestrants, and thiopurines, may be indicated to control the symptoms and enhance the quality of life of patients affected by this debilitating chronic disease, as recommended by international guidelines.

• #11 Microscopic Colitis: Dr. Falk Pharma international

  https://drfalkpharma.com/en/indications/microscopic-colitis/

  The disease can severely impact patients’ quality of life due to the symptoms described here. […] The process of collecting a patient’s complete medical history includes asking the patient about his or her prior medical history as well as current symptoms, how long they last, and how severe they are. […] The most important test for microscopic colitis is a colonoscopy. […] Targeted medications are available to treat microscopic colitis. […] The goal of this treatment is to alleviate the symptoms of the disease, or even to eliminate them entirely, so that patients experience a better quality of life for a long time. […] With microscopic colitis, is not necessary to switch to a special diet. […] Smoking is known to have a negative impact on the course of the disease. […] Because microscopic colitis is not a life-threatening disease, it usually has a benign outcome. […] However, if left untreated, about half of all patients will experience chronic or recurring diarrhea, which can massively impact their quality of life. […] Microscopic colitis does not increase the risk of developing colorectal cancer according to the current scientific knowledge.

• #12

  https://link.springer.com/article/10.1007/s40266-023-01094-6

  Microscopic colitis is a prevalent condition among older adults above the age of 60 years. […] Patients suspected with long-standing or recurrent non-bloody watery diarrhea should always be referred for colonoscopy with three biopsies from right and left colon followed by extensive histopathological evaluations. […] Oral budesonide is the drug of choice for microscopic colitis, but nonsteroidal medications, including bismuth subsalicylate, biologics, bile acid sequestrants, and supportive antidiarrheal drugs followed by thiopurines, may be useful alternatives. […] For the management of microscopic colitis, a treatment course with oral budesonide 9 mg/day for 68 weeks is considered first-line therapy. […] Accordingly, alternative therapeutics, including bismuth subsalicylate, biologics, bile acid sequestrants, and thiopurines, may be indicated to control the symptoms and enhance the quality of life of patients affected by this debilitating chronic disease, as recommended by international guidelines.

• #13 Microscopic Colitis | All you need to know | Gastro Health

  https://gastrohealth.com/news/patient-care/microscopic-colitis

  There is no evidence that microscopic colitis leads to an increase risk of colon cancer, as with ulcerative colitis. […] Management of microscopic colitis includes lifestyle changes aimed at reducing the diarrhea and discontinuing drugs like Nsaids and PPis. […] In many cases, treatment with antidiarrheal medications is necessary. Loperamide, Bismuth (Pepto Bismol), bulking agents like psyllium, or bile acid binding resins like cholestyramine are commonly used in the treatment of microscopic colitis. […] In more severe cases of diarrhea, corticosteroids can be used as treatment. Corticosteroids are medications that decrease inflammation and reduce the activity of the immune system. […] Therefore, this is the treatment of choice. […] Microscopic colitis is a chronic condition with symptoms that may come and go intermittently and cannot be diagnosed with blood tests or stool studies. […] In order to diagnose microscopic colitis, a physician must obtain a biopsy from the colon. […] In most cases, it can be easily treated and symptoms managed so patients can function normally.

• #14 SciELO Brazil – DIAGNOSIS AND TREATMENT OF MICROSCOPIC COLITIS: POSITION PAPER ON BEHALF OF THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY DIAGNOSIS AND TREATMENT OF MICROSCOPIC COLITIS: POSITION PAPER ON BEHALF OF THE BRAZILIAN FEDERATION OF GASTROENTEROL

  https://www.scielo.br/j/ag/a/tPZKRdCPbYCzSSxdgHZfwKL/

  Microscopic colitis (MC) is a chronic inflammatory condition of the colon, primarily characterized by watery diarrhea, with normal or near-normal endoscopic findings. […] This position paper from the Brazilian Federation of Gastroenterology aims to review current evidence on the diagnosis and management of MC in Brazil, emphasizing the need for standardization across the country’s healthcare systems. […] Histological examination with biopsies from multiple segments of the colon remains essential for the accurate diagnosis of MC, as endoscopic findings are often non-specific. Budesonide is the first-line treatment for inducing remission in most patients. However, alternatives such as immunosuppressants and biologics are available for those who are refractory to or intolerant of budesonide. Non-pharmacological interventions, including dietary and lifestyle modifications, can complement medical treatment. The need for long-term follow-up is highlighted due to the high recurrence rates and the impact of MC on the quality of life.

• #15 Undiagnosed microscopic colitis: a hidden cause of chronic diarrhoea and a frequently missed treatment opportunity | Frontline Gastroenterology

  https://fg.bmj.com/content/11/3/228

  Microscopic colitis (MC) is a treatable cause of chronic, non-bloody, watery diarrhoea, but physicians (particularly in primary care) are less familiar with MC than with other causes of chronic diarrhoea. […] MC can only be diagnosed by histological examination of colonic biopsies (subepithelial collagen band 10 m (collagenous colitis) or 20 intraepithelial lymphocytes per 100 epithelial cells (lymphocytic colitis), both with lamina propria inflammation). […] Clarity is needed around pathways for MC management; MC is poorly acknowledged by the UK healthcare system and it is unlikely that best practices are being followed adequately. There is an opportunity to identify and treat patients with MC more effectively. […] Initial management of MC should focus on eliminating (where possible) known risk factors, namely smoking and certain medications (proton pump inhibitors, non-steroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors and histamine-2 receptor antagonists).

• #16 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Use this nursing care plan and management guide to provide care for patients with inflammatory bowel disease (IBD). Enhance your understanding of nursing assessment, interventions, goals, and nursing diagnosis, all specifically tailored to address the unique needs of individuals with IBD. […] Nursing care management of clients with inflammatory bowel diseases (IBD) includes control of diarrhea and promoting optimal bowel function; minimizing or preventing complications; promoting optimal nutrition, and providing information about the disease process and treatment needs. […] The following are the nursing priorities for patients with inflammatory bowel disease (IBD): Manage and reduce inflammation in the gastrointestinal tract. Alleviate symptoms such as abdominal pain, diarrhea, and rectal bleeding. Monitor disease activity and assess response to treatment. Prevent and manage complications, such as intestinal strictures or fistulas. Provide nutritional support and guidance to manage nutritional deficiencies. Administer appropriate medications to control inflammation and suppress the immune response. Educate patients on self-care measures and lifestyle modifications to manage symptoms. Offer support for emotional well-being and address the psychosocial impact of living with IBD.

• #17 Partners in Care | Microscopic colitis treatment at Digestive Health

  https://partnersincare.health/conditions/microscopic-colitis

  Patients are cared for by a dedicated multidisciplinary care team, meaning you will benefit from the expertise of multiple specialists across a variety of disciplines. […] Our board-certified and fellowship-trained gastroenterologists have extensive experience with microscopic colitis and work alongside a team of digestive health experts, including colorectal surgeons, gastrointestinal-specialized dietitians, clinical social workers, physician assistants, nurses, advanced practice providers, and more, providing unparalleled care for patients every step of the way. […] We are committed to communicating and coordinating your care with referring physicians and other partners in the community to ensure that we are providing you with comprehensive, whole-person care.

• #18 Partners in Care | Microscopic colitis treatment at Digestive Health

  https://partnersincare.health/conditions/microscopic-colitis

  Patients are cared for by a dedicated multidisciplinary care team, meaning you will benefit from the expertise of multiple specialists across a variety of disciplines. […] Our board-certified and fellowship-trained gastroenterologists have extensive experience with microscopic colitis and work alongside a team of digestive health experts, including colorectal surgeons, gastrointestinal-specialized dietitians, clinical social workers, physician assistants, nurses, advanced practice providers, and more, providing unparalleled care for patients every step of the way. […] We are committed to communicating and coordinating your care with referring physicians and other partners in the community to ensure that we are providing you with comprehensive, whole-person care.

• #19 Partners in Care | Microscopic colitis treatment at Digestive Health

  https://partnersincare.health/conditions/microscopic-colitis

  Patients are cared for by a dedicated multidisciplinary care team, meaning you will benefit from the expertise of multiple specialists across a variety of disciplines. […] Our board-certified and fellowship-trained gastroenterologists have extensive experience with microscopic colitis and work alongside a team of digestive health experts, including colorectal surgeons, gastrointestinal-specialized dietitians, clinical social workers, physician assistants, nurses, advanced practice providers, and more, providing unparalleled care for patients every step of the way. […] We are committed to communicating and coordinating your care with referring physicians and other partners in the community to ensure that we are providing you with comprehensive, whole-person care.

• #20 Colitis and Crohn’s Disease Center | UCSF Health

  https://www.ucsfhealth.org/clinics/colitis-and-crohns-disease-center

  The UCSF Colitis and Crohn’s Disease Center provides comprehensive care for people with inflammatory bowel disease (IBD), including Crohn’s disease, ulcerative colitis, microscopic or collagenous colitis, and related illnesses. […] Our specialists are dedicated to providing every patient with high-quality care, and they’re at the forefront of research to develop new IBD treatments and find a cure. […] Team members work closely together and meet regularly to develop personalized treatment plans for all patients. […] Our goal is to improve our patients’ quality of life and get them back to doing the things they love. […] This digital health tool helps your care team monitor your health between visits.

• #21 Partners in Care | Microscopic colitis treatment at Digestive Health

  https://partnersincare.health/conditions/microscopic-colitis

  Patients are cared for by a dedicated multidisciplinary care team, meaning you will benefit from the expertise of multiple specialists across a variety of disciplines. […] Our board-certified and fellowship-trained gastroenterologists have extensive experience with microscopic colitis and work alongside a team of digestive health experts, including colorectal surgeons, gastrointestinal-specialized dietitians, clinical social workers, physician assistants, nurses, advanced practice providers, and more, providing unparalleled care for patients every step of the way. […] We are committed to communicating and coordinating your care with referring physicians and other partners in the community to ensure that we are providing you with comprehensive, whole-person care.

• #22 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Therapeutic interventions and nursing actions for patients with inflammatory bowel disease (IBD) may include: Enhancing Bowel Function and Managing Diarrhea. The intestinal immune system is key to the pathogenesis of inflammatory bowel disease (IBD). The intestinal epithelium prevents bacteria or antigen entry into the circulation by sealed intercellular junctions. In IBD, these junctions are defective from either a primary barrier function failure or as a result of severe inflammation. […] Promote bedrest and provide bedside commode. Rest decreases intestinal motility and reduces the metabolic rate when infection or hemorrhage is a complication. […] Identify and restrict foods and fluids that precipitate diarrhea (vegetables and fruits, whole-grain cereals, condiments, carbonated drinks, and milk products). Avoiding intestinal irritants promotes intestinal rest and reduces intestinal workload.

• #23 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Administer cholestyramine as indicated. In clients with Crohns disease who have a significant ileal disease or who have had an ileal resection, diarrhea may sometimes occur due to bile salt malabsorption. […] Administer topical corticosteroids or aminosalicylate preparations as prescribed. These agents reduce mucosal inflammation in clients with mild disease limited to the rectum and sigmoid colon. […] Administer probiotics or fish oil. Probiotics are beneficial bacteria that restore balance to the intestinal environment, with a resulting reduction in inflammation. […] Clients diagnosed with IBD may have difficulty absorbing nutrients, including water, from the food they consume. This can lead to dehydration over time, as the body may not be able to absorb enough water to meet its requirements.

• #24 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Administer cholestyramine as indicated. In clients with Crohns disease who have a significant ileal disease or who have had an ileal resection, diarrhea may sometimes occur due to bile salt malabsorption. […] Administer topical corticosteroids or aminosalicylate preparations as prescribed. These agents reduce mucosal inflammation in clients with mild disease limited to the rectum and sigmoid colon. […] Administer probiotics or fish oil. Probiotics are beneficial bacteria that restore balance to the intestinal environment, with a resulting reduction in inflammation. […] Clients diagnosed with IBD may have difficulty absorbing nutrients, including water, from the food they consume. This can lead to dehydration over time, as the body may not be able to absorb enough water to meet its requirements.

• #25 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Monitor IO. Note the number, character, and amount of stools; estimate insensible fluid losses (diaphoresis). Measure urine specific gravity; observe for oliguria. […] Assess vital signs (BP, pulse, temperature). Hypotension (including postural), tachycardia, and fever can indicate a response to fluid loss. […] Observe for excessively dry skin and mucous membranes decreased skin turgor and slowed capillary refill. These signs may indicate excessive fluid loss or resultant dehydration. […] Provide a bland, high-protein, high-calorie, low-residue diet as prescribed, when the client resumes oral intake. Nutritional management varies with the clients condition. […] Educate the client about behaviors that contribute to dysfunctional coping. A number of studies examined coping strategies in relation to pain levels. Greater use of behaviors such as self-distraction, behavioral disengagement, denial, venting, and self-blame and less use of active coping and planning were related to increased pain severity in IBD.

• #26 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Monitor IO. Note the number, character, and amount of stools; estimate insensible fluid losses (diaphoresis). Measure urine specific gravity; observe for oliguria. […] Assess vital signs (BP, pulse, temperature). Hypotension (including postural), tachycardia, and fever can indicate a response to fluid loss. […] Observe for excessively dry skin and mucous membranes decreased skin turgor and slowed capillary refill. These signs may indicate excessive fluid loss or resultant dehydration. […] Provide a bland, high-protein, high-calorie, low-residue diet as prescribed, when the client resumes oral intake. Nutritional management varies with the clients condition. […] Educate the client about behaviors that contribute to dysfunctional coping. A number of studies examined coping strategies in relation to pain levels. Greater use of behaviors such as self-distraction, behavioral disengagement, denial, venting, and self-blame and less use of active coping and planning were related to increased pain severity in IBD.

• #27

  https://carle.org/conditions/digestive-health/microscopic-colitis

  Lifestyle changes to stop diarrhea are usually tried first. […] DO avoid eating problem foods such as fat, caffeine, and lactose (milk sugar found in dairy products). Avoid spicy foods and alcohol. Stay away from foods that cause gas and diarrhea: carbonated beverages, raw fruits, and vegetables such as beans, cauliflower, broccoli, and cabbage. […] DO talk to your health care provider about using pain relievers other than NSAIDs. NSAIDs can worsen diarrhea. […] DO ask your health care provider whether you should drink an oral rehydration solution (ORS). Severe diarrhea can cause dehydration. An ORS has the right amounts of water, salts, and sugar to replace body fluids. […] DO look into eating a gluten-free diet. Microscopic colitis may respond to this diet. […] DO learn all you can about microscopic colitis. […] DO join a support group if you think that would help.

• #28 Microscopic colitis – Symptoms, diagnosis and treatment | BMJ Best Practice US

  https://bestpractice.bmj.com/topics/en-us/3000315

  Microscopic colitis typically presents in people 50 years with chronic, nonbloody, watery diarrhea and is more common in women than in men. Other common symptoms include fecal urgency, fecal incontinence, and nocturnal stools. Symptoms can lead to a significantly impaired quality of life. […] Treatment aims to achieve clinical remission (3 stools per day and 1 watery stool per day) and improve quality of life. Drug choice depends on the severity and extent of disease and includes antidiarrheals, bismuth subsalicylate, oral budesonide, bile acid sequestrants, and immunosuppressants or biologic agents. All patients should additionally have modification of contributing factors, including diet changes if appropriate, avoiding/withdrawing culprit medications, and encouraging cigarette smokers to cease. […] Despite high rates of response to medical treatment, the relapse rate after discontinuation is 60% to 80% of patients with variable time to relapse. In patients with recurrent disease, consider re-treatment with prior therapies or with biologics for patients with severe refractory symptoms.

• #29 Microscopic colitis – IBD Clinic

  https://ibdclinic.ca/what-is-ibd/microscopic-colitis/

  Microscopic Colitis is an inflammatory bowel disease that affects the large bowel (colon and rectum) and was first recognized by doctors 40 years ago. […] This web page provides a brief overview of Microscopic Colitis, including diagnosis, possible causes, and treatments. […] The main symptom of Microscopic Colitis is chronic (ongoing) watery diarrhea, which may begin very suddenly. […] If you are taking any of the drugs mentioned previously as possible triggers for Microscopic Colitis, then you may be asked to change or decrease the medication. […] If none of the steps mentioned above has improved your symptoms, you might need to take medication for your Microscopic Colitis. […] The main goal of treatment is to achieve clinical remission (freedom from symptoms) and improve the quality of life.

• #30 Treating Microscopic Colitis

  https://consultqd.clevelandclinic.org/microscopic-colitis-what-is-it-and-what-are-the-treatment-options

  Microscopic colitis, an inflammatory disorder characterized by chronic diarrhea, is so named because its diagnosis requires histologic evaluation with mucosal biopsy. […] A standard approach to therapy improves symptoms and quality of life. […] First-line therapy for microscopic colitis, regardless of the subtype, is budesonide 9 mg/day for eight weeks. […] If the patient is symptom-free after eight weeks, budesonide therapy can be stopped. […] If the patient remains symptomatic at the end of eight weeks or if symptoms recur, then budesonide can be continued or resumed at the lowest effective dose, usually 6 mg/day or less, for six to 12 months. […] Patients should be advised to avoid smoking and using nonsteroidal anti-inflammatory drugs. […] If possible, they should discontinue all associated medications, including proton pump inhibitors, statins, aspirin, immune checkpoint inhibitors and selective serotonin reuptake inhibitors.

• #31 Microscopic colitis: a guide for general practice | British Journal of General Practice

  https://bjgp.org/content/71/702/41

  Microscopic colitis cannot be diagnosed in primary care. […] The initial treatment for most patients with microscopic colitis is oral budesonide at a dose of 9 mg/day for a period of 68 weeks; 81%84% of patients respond successfully to treatment compared with 36%43% given a placebo. […] Patients may enter and stay in remission at this point; however, some studies have shown that patients may need long-term budesonide (for at least 6 months) at 3 mg or 6 mg/day but this should be titrated according to clinical response. […] Prednisolone, loperamide, bismuth, mesalazine, antibiotics, or probiotics are not recommended treatments. […] A summary of the information on microscopic colitis is shown in Box 1. […] Treatment is with oral budesonide 9 mg/day for an initial period of 68 weeks.

• #32 Medical management of microscopic colitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/medical-management-of-microscopic-colitis/

  1. A guide to selecting treatments for patients with microscopic colitis. […] […] 2. In patients with symptomatic microscopic colitis, AGA recommends treatment with budesonide over no treatment for the induction of clinical remission. […] 3. In patients with symptomatic microscopic colitis, AGA recommends treatment with budesonide over mesalamine for the induction of clinical remission. […] 4. In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, AGA suggests treatment with mesalamine over no treatment for the induction of clinical remission. […] 5. In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, AGA suggests treatment with bismuth salicylate over no treatment for the induction of clinical remission.

• #33 Microscopic colitis: a guide for general practice | British Journal of General Practice

  https://bjgp.org/content/71/702/41

  Microscopic colitis cannot be diagnosed in primary care. […] The initial treatment for most patients with microscopic colitis is oral budesonide at a dose of 9 mg/day for a period of 68 weeks; 81%84% of patients respond successfully to treatment compared with 36%43% given a placebo. […] Patients may enter and stay in remission at this point; however, some studies have shown that patients may need long-term budesonide (for at least 6 months) at 3 mg or 6 mg/day but this should be titrated according to clinical response. […] Prednisolone, loperamide, bismuth, mesalazine, antibiotics, or probiotics are not recommended treatments. […] A summary of the information on microscopic colitis is shown in Box 1. […] Treatment is with oral budesonide 9 mg/day for an initial period of 68 weeks.

• #34 Treating Microscopic Colitis

  https://consultqd.clevelandclinic.org/microscopic-colitis-what-is-it-and-what-are-the-treatment-options

  Microscopic colitis, an inflammatory disorder characterized by chronic diarrhea, is so named because its diagnosis requires histologic evaluation with mucosal biopsy. […] A standard approach to therapy improves symptoms and quality of life. […] First-line therapy for microscopic colitis, regardless of the subtype, is budesonide 9 mg/day for eight weeks. […] If the patient is symptom-free after eight weeks, budesonide therapy can be stopped. […] If the patient remains symptomatic at the end of eight weeks or if symptoms recur, then budesonide can be continued or resumed at the lowest effective dose, usually 6 mg/day or less, for six to 12 months. […] Patients should be advised to avoid smoking and using nonsteroidal anti-inflammatory drugs. […] If possible, they should discontinue all associated medications, including proton pump inhibitors, statins, aspirin, immune checkpoint inhibitors and selective serotonin reuptake inhibitors.

• #35 Medical management of microscopic colitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/medical-management-of-microscopic-colitis/

  1. A guide to selecting treatments for patients with microscopic colitis. […] […] 2. In patients with symptomatic microscopic colitis, AGA recommends treatment with budesonide over no treatment for the induction of clinical remission. […] 3. In patients with symptomatic microscopic colitis, AGA recommends treatment with budesonide over mesalamine for the induction of clinical remission. […] 4. In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, AGA suggests treatment with mesalamine over no treatment for the induction of clinical remission. […] 5. In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, AGA suggests treatment with bismuth salicylate over no treatment for the induction of clinical remission.

• #36 Medical management of microscopic colitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/medical-management-of-microscopic-colitis/

  6. In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, AGA suggests treatment with prednisolone (or prednisone) over no treatment for the induction of clinical remission. […] 7. In patients with symptomatic microscopic colitis, AGA suggests against combination therapy with cholestyramine and mesalamine over mesalamine alone for the induction of clinical remission. […] 8. In patients with symptomatic microscopic colitis, AGA suggests against treatment with Boswellia serrata over no treatment for the induction of clinical remission. […] 9. In patients with symptomatic microscopic colitis, AGA suggests against treatment with probiotics over no treatment for the induction of clinical remission. […] 10. In patients with recurrence of symptoms following discontinuation of induction therapy for microscopic colitis, AGA recommends budesonide for maintenance of clinical remission.

• #37 Management of microscopic colitis: challenges and solutions | CEG

  https://www.dovepress.com/management-of-microscopic-colitis-challenges-and-solutions-peer-reviewed-fulltext-article-CEG

  In glucocorticoid refractory disease, medications that have been tried include cholestyramine, bismuth salicylate, antibiotics, probiotics, aminosalicylates, immunomodulators, and anti-tumor necrosis factor-alpha inhibitors. […] The overall goal in the management of MC is symptomatic improvement, the exact definition of which varies greatly between studies. […] Lifestyle modifications including decreasing caffeine, dairy (in patients with lactose intolerance), and alcohol consumption may improve the diarrhea seen in MC. […] Withdrawal of medications that have been implicated in causing MC may be considered as an addition to the standard first-line therapy. […] Loperamide was until recently the only identified therapy for MC. […] Budesonide is an oral corticosteroid with very low systemic bioavailability.

• #38 Medical management of microscopic colitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/medical-management-of-microscopic-colitis/

  6. In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, AGA suggests treatment with prednisolone (or prednisone) over no treatment for the induction of clinical remission. […] 7. In patients with symptomatic microscopic colitis, AGA suggests against combination therapy with cholestyramine and mesalamine over mesalamine alone for the induction of clinical remission. […] 8. In patients with symptomatic microscopic colitis, AGA suggests against treatment with Boswellia serrata over no treatment for the induction of clinical remission. […] 9. In patients with symptomatic microscopic colitis, AGA suggests against treatment with probiotics over no treatment for the induction of clinical remission. […] 10. In patients with recurrence of symptoms following discontinuation of induction therapy for microscopic colitis, AGA recommends budesonide for maintenance of clinical remission.

• #39 Medical management of microscopic colitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/medical-management-of-microscopic-colitis/

  6. In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, AGA suggests treatment with prednisolone (or prednisone) over no treatment for the induction of clinical remission. […] 7. In patients with symptomatic microscopic colitis, AGA suggests against combination therapy with cholestyramine and mesalamine over mesalamine alone for the induction of clinical remission. […] 8. In patients with symptomatic microscopic colitis, AGA suggests against treatment with Boswellia serrata over no treatment for the induction of clinical remission. […] 9. In patients with symptomatic microscopic colitis, AGA suggests against treatment with probiotics over no treatment for the induction of clinical remission. […] 10. In patients with recurrence of symptoms following discontinuation of induction therapy for microscopic colitis, AGA recommends budesonide for maintenance of clinical remission.

• #40 Treating Microscopic Colitis

  https://consultqd.clevelandclinic.org/microscopic-colitis-what-is-it-and-what-are-the-treatment-options

  With effective treatment, symptoms and quality of life improve with microscopic colitis. […] As a general rule, continued budesonide therapy may be indicated for patients who are not in remission after six to 12 months. […] The goal of continued treatment is clinical (i.e., symptomatic) remission.

• #41 Management of microscopic colitis: challenges and solutions | CEG

  https://www.dovepress.com/management-of-microscopic-colitis-challenges-and-solutions-peer-reviewed-fulltext-article-CEG

  The 2016 AGA clinical guideline for the management of MC recommends that budesonide be used as first-line therapy. […] Despite the effectiveness of budesonide, relapse rates have been reported at 40%81% and can occur as soon as 2 weeks after cessation of therapy. […] Bismuth salicylate is recommended by the 2016 AGA guideline as a second-line therapy for MC when budesonide is unable to be used, either due to cost or adverse effects. […] Cholestyramine is thought to play a role in the treatment of MC due to its bile acid-binding capacity. […] AGA recommends against treatment with Boswellia serrata as well as other probiotics. […] Mesalamine can be considered as an alternative to budenoside therapy when the latter is not feasible due to contraindications or poor clinical response. […] Immunomodulators such as azathioprine or 6-MP may have a role in the treatment of severe, steroid dependent, or refractory disease. […] The use of anti-TNF-alpha drugs in MC can be considered for refractory cases as rescue therapy prior to surgical intervention. […] The role of surgical management in MC is diminishing with considerable improvement and efficacy of available medical therapy.

• #42 Microscopic colitis: A review of etiology, treatment and refractory disease

  https://www.wjgnet.com/1007-9327/full/v21/i29/8804.htm

  Microscopic colitis is a common cause of chronic, nonbloody diarrhea. This article reviews the etiology and medical management of microscopic colitis. Multiple medications, including corticosteroids, anti-diarrheals, cholestyramine, bismuth, 5-aminosalicylates, and immunomodulators, have been used to treat microscopic colitis with variable response rates. Budesonide is effective in inducing and maintaining clinical remission but relapse rate is as high as 82% when budesonide is discontinued. There is limited data on management of steroid-dependent microscopic colitis or refractory microscopic colitis. Immunomodulators seem to have low response rate 0%-56% for patients with refractory microscopic colitis. Response rate 66%-100% was observed for use of anti-tumor necrosis factor (TNF) therapy for refractory microscopic colitis. Anti-TNF and diverting ileostomy may be an option in severe or refractory microscopic colitis.

• #43 Management of microscopic colitis: challenges and solutions | CEG

  https://www.dovepress.com/management-of-microscopic-colitis-challenges-and-solutions-peer-reviewed-fulltext-article-CEG

  The 2016 AGA clinical guideline for the management of MC recommends that budesonide be used as first-line therapy. […] Despite the effectiveness of budesonide, relapse rates have been reported at 40%81% and can occur as soon as 2 weeks after cessation of therapy. […] Bismuth salicylate is recommended by the 2016 AGA guideline as a second-line therapy for MC when budesonide is unable to be used, either due to cost or adverse effects. […] Cholestyramine is thought to play a role in the treatment of MC due to its bile acid-binding capacity. […] AGA recommends against treatment with Boswellia serrata as well as other probiotics. […] Mesalamine can be considered as an alternative to budenoside therapy when the latter is not feasible due to contraindications or poor clinical response. […] Immunomodulators such as azathioprine or 6-MP may have a role in the treatment of severe, steroid dependent, or refractory disease. […] The use of anti-TNF-alpha drugs in MC can be considered for refractory cases as rescue therapy prior to surgical intervention. […] The role of surgical management in MC is diminishing with considerable improvement and efficacy of available medical therapy.

• #44 Microscopic Colitis and Diet: What to Eat, Avoid, and More

  https://www.healthline.com/health/microscopic-colitis-diet

  Theres no specific diet for people with microscopic colitis, but eating foods like plain rice, low fat dairy, and bananas may help symptoms. […] Managing symptoms like watery diarrhea, abdominal cramping, and fecal incontinence may be challenging. […] Treatment usually involves taking medication to help ease your symptoms. However, a healthcare professional may also recommend natural remedies, such as dietary changes. […] No specific diets are associated with improving or worsening symptoms of microscopic colitis. […] That said, if youre experiencing a bout of diarrhea, the International Foundation for Gastrointestinal Disorders (IFFGD) recommends trying the BRAT diet. […] The BRAT diet may help slow down digestion and reduce the frequency of bowel movements. However, this diet should only be followed temporarily during a flare-up.

• #45 Microscopic Colitis Disease Diet: Foods to Eat & Avoid

  https://zayacare.com/blog/microscopic-colitis-disease-diet/

  Most people with microscopic colitis benefit from eating a low-fiber, low-fat diet that avoids spicy foods, fried foods, and alcohol. Some people also benefit from eliminating dairy and gluten. […] While there is no specific diet for microscopic colitis, most people find that following a low-fiber, low-fat diet is beneficial. Foods that are typically eliminated from ones diet are spicy foods, alcohol, fried foods, gluten, and dairy because they can often cause digestive issues. […] Since everyone has different tolerances and preferences, it is important to learn what works best for you. […] While you are experiencing symptoms, stick to bland, low-fiber, low-fat foods until your symptoms resolve. Foods that can help during a flare-up include white rice, white bread, applesauce, and bananas.

• #46 Microscopic Colitis and Diet: What to Eat, Avoid, and More

  https://www.healthline.com/health/microscopic-colitis-diet

  Theres no specific diet for people with microscopic colitis, but eating foods like plain rice, low fat dairy, and bananas may help symptoms. […] Managing symptoms like watery diarrhea, abdominal cramping, and fecal incontinence may be challenging. […] Treatment usually involves taking medication to help ease your symptoms. However, a healthcare professional may also recommend natural remedies, such as dietary changes. […] No specific diets are associated with improving or worsening symptoms of microscopic colitis. […] That said, if youre experiencing a bout of diarrhea, the International Foundation for Gastrointestinal Disorders (IFFGD) recommends trying the BRAT diet. […] The BRAT diet may help slow down digestion and reduce the frequency of bowel movements. However, this diet should only be followed temporarily during a flare-up.

• #47 Microscopic Colitis and Diet: What to Eat, Avoid, and More

  https://www.healthline.com/health/microscopic-colitis-diet

  Eating foods that could help relieve diarrhea may be helpful if you have microscopic colitis. […] According to the IFFGD, these may include: low fat dairy, such as yogurt, plain rice, noodles, or white bread, lean meats, cream of wheat, peanut butter (only smooth and a little at a time). […] You should also stay hydrated by drinking water and other fluids, such as broth or sports drinks containing sodium and potassium. […] The National Institute of Diabetes and Digestive and Kidney Diseases suggests avoiding or limiting the following foods if you have microscopic colitis: alcohol, coffee, artificial sweeteners, gluten, if you have celiac disease, dairy, if you have lactose intolerance. […] If you dont know which foods to eat or avoid, speak with a registered dietitian or healthcare professional.

• #48 Microscopic Colitis and Diet: What to Eat, Avoid, and More

  https://www.healthline.com/health/microscopic-colitis-diet

  Eating foods that could help relieve diarrhea may be helpful if you have microscopic colitis. […] According to the IFFGD, these may include: low fat dairy, such as yogurt, plain rice, noodles, or white bread, lean meats, cream of wheat, peanut butter (only smooth and a little at a time). […] You should also stay hydrated by drinking water and other fluids, such as broth or sports drinks containing sodium and potassium. […] The National Institute of Diabetes and Digestive and Kidney Diseases suggests avoiding or limiting the following foods if you have microscopic colitis: alcohol, coffee, artificial sweeteners, gluten, if you have celiac disease, dairy, if you have lactose intolerance. […] If you dont know which foods to eat or avoid, speak with a registered dietitian or healthcare professional.

• #49

  https://carle.org/conditions/digestive-health/microscopic-colitis

  Lifestyle changes to stop diarrhea are usually tried first. […] DO avoid eating problem foods such as fat, caffeine, and lactose (milk sugar found in dairy products). Avoid spicy foods and alcohol. Stay away from foods that cause gas and diarrhea: carbonated beverages, raw fruits, and vegetables such as beans, cauliflower, broccoli, and cabbage. […] DO talk to your health care provider about using pain relievers other than NSAIDs. NSAIDs can worsen diarrhea. […] DO ask your health care provider whether you should drink an oral rehydration solution (ORS). Severe diarrhea can cause dehydration. An ORS has the right amounts of water, salts, and sugar to replace body fluids. […] DO look into eating a gluten-free diet. Microscopic colitis may respond to this diet. […] DO learn all you can about microscopic colitis. […] DO join a support group if you think that would help.

• #50 Microscopic colitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/microscopic-colitis/diagnosis-treatment/drc-20351483

  Our caring team of Mayo Clinic experts can help you with your microscopic colitis-related health concerns […] Treatment usually begins with changes to your diet and medicines that may help relieve diarrhea. Your healthcare professional might suggest that you: […] If you keep having symptoms, your healthcare professional may suggest: […] You may find some relief from diarrhea by making changes to your diet: […] Don’t have dairy products, spicy foods, caffeine and alcohol.

• #51 Treating Microscopic Colitis

  https://consultqd.clevelandclinic.org/microscopic-colitis-what-is-it-and-what-are-the-treatment-options

  Microscopic colitis, an inflammatory disorder characterized by chronic diarrhea, is so named because its diagnosis requires histologic evaluation with mucosal biopsy. […] A standard approach to therapy improves symptoms and quality of life. […] First-line therapy for microscopic colitis, regardless of the subtype, is budesonide 9 mg/day for eight weeks. […] If the patient is symptom-free after eight weeks, budesonide therapy can be stopped. […] If the patient remains symptomatic at the end of eight weeks or if symptoms recur, then budesonide can be continued or resumed at the lowest effective dose, usually 6 mg/day or less, for six to 12 months. […] Patients should be advised to avoid smoking and using nonsteroidal anti-inflammatory drugs. […] If possible, they should discontinue all associated medications, including proton pump inhibitors, statins, aspirin, immune checkpoint inhibitors and selective serotonin reuptake inhibitors.

• #52

  https://link.springer.com/article/10.1007/s40266-023-01094-6

  All patients diagnosed with microscopic colitis should be recommended to stop smoking and any culprit medication should be discontinued. […] Although the current treatment options for microscopic colitis are affiliated with limitations, the management of microscopic colitis aims to resolve symptoms and, in this way, improve the quality of life of these patients. […] Nevertheless, even if a standard treatment regimen with budesonide (9 mg daily for 68 weeks) is usually prescribed, it is still unclear as to how long patients with microscopic colitis on the alternative treatment options should be treated, or if any prophylactic therapy exists. […] Finally, as microscopic colitis—a chronic disease with recurrent non-bloody, secretory diarrhea—can be a disabling life experience with impacts on every aspect of patients’ lives, including urgency and often unpredictable fecal incontinence, patients with symptoms should be offered regular follow-ups, and all elderly individuals with microscopic colitis should have easy access to a gastroenterologist in case of flaring disease.

• #53 Undiagnosed microscopic colitis: a hidden cause of chronic diarrhoea and a frequently missed treatment opportunity | Frontline Gastroenterology

  https://fg.bmj.com/content/11/3/228

  Microscopic colitis (MC) is a treatable cause of chronic, non-bloody, watery diarrhoea, but physicians (particularly in primary care) are less familiar with MC than with other causes of chronic diarrhoea. […] MC can only be diagnosed by histological examination of colonic biopsies (subepithelial collagen band 10 m (collagenous colitis) or 20 intraepithelial lymphocytes per 100 epithelial cells (lymphocytic colitis), both with lamina propria inflammation). […] Clarity is needed around pathways for MC management; MC is poorly acknowledged by the UK healthcare system and it is unlikely that best practices are being followed adequately. There is an opportunity to identify and treat patients with MC more effectively. […] Initial management of MC should focus on eliminating (where possible) known risk factors, namely smoking and certain medications (proton pump inhibitors, non-steroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors and histamine-2 receptor antagonists).

• #54 Microscopic Colitis Disease Diet: Foods to Eat & Avoid

  https://zayacare.com/blog/microscopic-colitis-disease-diet/

  Just as certain foods can help symptoms; others can trigger them. Spicy, high-fiber, and high-fat foods are often irritating to the intestines and are common foods that need to be avoided if you have microscopic colitis. […] Knowing which foods trigger your symptoms starts with paying close attention to what you are eating and when your symptoms occur. […] When you have identified your trigger foods, you may need to limit or completely avoid those foods long-term to prevent symptoms. […] Managing microscopic colitis goes beyond medication. Diet and lifestyle habits can make a big difference in disease outcomes. […] A microscopic colitis nutritionist can guide you into making the proper food choices based on your symptoms and your unique situation. […] Resolving symptoms of microscopic colitis through diet is possible. However, figuring out what to eat can be difficult to do on your own. Seeking help from a microscopic colitis nutritionist can be very beneficial to you and your health.

• #55 BATTLING MICROSCOPIC COLITIS: PROGNOSIS, TYPES, PREVENTION, AND TREATMENT | Mya Care

  https://myacare.com/blog/battling-microscopic-colitis-prognosis-types-prevention-and-treatment

  Microscopic colitis is classified as an inflammatory bowel disease (IBD) known to affect the colon or large intestine. Chronic watery diarrhea and colonic inflammation are the hallmark features of the condition. […] It is crucial to consult a doctor to receive suitable treatment and advice for managing the symptoms effectively. […] Despite the lack of a cure for microscopic colitis, treatments are available to manage the symptoms and improve quality of life. Treatment options include prophylactic prescription medication and dietary changes. […] Managing triggers is a critical aspect of preventing flares of microscopic colitis. […] Individuals with microscopic colitis can reduce the frequency and severity of flare-ups by identifying and avoiding these triggers. […] Working closely with a healthcare professional is highly recommended to manage your triggers and prevent symptoms.

• #56 Microscopic Colitis – GI Urgent Care of Florida | Gastroenterologist in Orlando, FL

  https://www.giurgentcare.com/articles/general/955900-microscopic-colitis

  Adopting lifestyle changes and modifying dietary habits can significantly contribute to managing microscopic colitis. Eliminating trigger foods, maintaining a food diary, and staying well-hydrated are essential steps. Fiber-rich foods can also play a crucial role in symptom relief. This holistic approach empowers individuals to actively participate in their well-being and enhance their overall quality of life. […] Coping with microscopic colitis involves not only medical interventions but also emotional and social support. Engaging with healthcare professionals, joining support groups, and staying informed about the latest research developments can provide valuable insights. Empowering individuals with knowledge and fostering a sense of community are essential elements in the holistic approach to managing microscopic colitis.

• #57 Microscopic Colitis – GI Urgent Care of Florida | Gastroenterologist in Orlando, FL

  https://www.giurgentcare.com/articles/general/955900-microscopic-colitis

  Adopting lifestyle changes and modifying dietary habits can significantly contribute to managing microscopic colitis. Eliminating trigger foods, maintaining a food diary, and staying well-hydrated are essential steps. Fiber-rich foods can also play a crucial role in symptom relief. This holistic approach empowers individuals to actively participate in their well-being and enhance their overall quality of life. […] Coping with microscopic colitis involves not only medical interventions but also emotional and social support. Engaging with healthcare professionals, joining support groups, and staying informed about the latest research developments can provide valuable insights. Empowering individuals with knowledge and fostering a sense of community are essential elements in the holistic approach to managing microscopic colitis.

• #58 Caroline’s Story – Microscopic Colitis – Guts UK

  https://gutscharity.org.uk/advice-and-information/personal-stories/carolines-story-microscopic-colitis/

  Caroline was going to the toilet around 20 times a day and woke up in the night with it too. She was continually misdiagnosed until finally she was given the correct diagnosis of microscopic colitis. […] The college I work for was really supportive. They allowed me to move from Teaching Assistant to a customer service role, which was desk-based and much easier for me. […] The IBD nurses whose care I’m under are amazing too. I can call them at any time and they’re always there to help. […] Within days of diagnosis, I was on steroids (budesonide). I was finally able to eat as soon as I started taking these steroids. My diarrhoea improved and was nowhere near as bad as it used to be, but I still do experience diarrhoea and fatigue on a daily basis. […] On a really bad day, I’ll allow myself to spend the day in bed and I tend to feel much better the following day. […] The thought of people going through what I did, misdiagnosed and struggling makes me so sad. This was a horrible time for me, and I want to try and help as many people as I can get the correct diagnosis and treatment.

• #59 Caroline’s Story – Microscopic Colitis – Guts UK

  https://gutscharity.org.uk/advice-and-information/personal-stories/carolines-story-microscopic-colitis/

  Caroline was going to the toilet around 20 times a day and woke up in the night with it too. She was continually misdiagnosed until finally she was given the correct diagnosis of microscopic colitis. […] The college I work for was really supportive. They allowed me to move from Teaching Assistant to a customer service role, which was desk-based and much easier for me. […] The IBD nurses whose care I’m under are amazing too. I can call them at any time and they’re always there to help. […] Within days of diagnosis, I was on steroids (budesonide). I was finally able to eat as soon as I started taking these steroids. My diarrhoea improved and was nowhere near as bad as it used to be, but I still do experience diarrhoea and fatigue on a daily basis. […] On a really bad day, I’ll allow myself to spend the day in bed and I tend to feel much better the following day. […] The thought of people going through what I did, misdiagnosed and struggling makes me so sad. This was a horrible time for me, and I want to try and help as many people as I can get the correct diagnosis and treatment.

• #60 UNC Researchers Reveal Prevalence of Persistent Symptoms in Patients with Microscopic Colitis | Newsroom

  https://news.unchealthcare.org/2023/12/unc-researchers-reveal-prevalence-of-colonoscopy-miscommunication-with-microscopic-colitis-patients/

  We thought it was important to better understand the burden of symptoms among those patients with microscopic colitis within the context of all patients undergoing colonoscopy to evaluate diarrhea, Redd said. […] These results highlight how clear communication is needed to address next steps after a diagnosis of the chronic disease. […] Identifying and addressing gaps in the communication of diagnostic results is an important area for future research. […] The first line therapy recommended for microscopic colitis is budesonide. However, findings show 46% of cases received that kind of treatment. […] In addition, many cases continued to experience ongoing loose stools, urgency, and fecal incontinence at one year, providing further evidence that patients should be offered follow-up appointments to assess how they are responding to treatment.

• #61 UNC Researchers Reveal Prevalence of Persistent Symptoms in Patients with Microscopic Colitis | Newsroom

  https://news.unchealthcare.org/2023/12/unc-researchers-reveal-prevalence-of-colonoscopy-miscommunication-with-microscopic-colitis-patients/

  Hopefully, these findings will help increase awareness of the importance of communicating diagnostic colonoscopy findings as well as assessing and treating persistent symptoms following an initial diagnostic evaluation, said Redd. […] Furthermore, follow-up appointments, education, and communication can be used to empower patients as far as understanding the implications of a new microscopic colitis diagnosis and how to manage the disease.

• #62 Microscopic Colitis: Dr. Falk Pharma international

  https://drfalkpharma.com/en/indications/microscopic-colitis/

  The disease can severely impact patients’ quality of life due to the symptoms described here. […] The process of collecting a patient’s complete medical history includes asking the patient about his or her prior medical history as well as current symptoms, how long they last, and how severe they are. […] The most important test for microscopic colitis is a colonoscopy. […] Targeted medications are available to treat microscopic colitis. […] The goal of this treatment is to alleviate the symptoms of the disease, or even to eliminate them entirely, so that patients experience a better quality of life for a long time. […] With microscopic colitis, is not necessary to switch to a special diet. […] Smoking is known to have a negative impact on the course of the disease. […] Because microscopic colitis is not a life-threatening disease, it usually has a benign outcome. […] However, if left untreated, about half of all patients will experience chronic or recurring diarrhea, which can massively impact their quality of life. […] Microscopic colitis does not increase the risk of developing colorectal cancer according to the current scientific knowledge.

• #63 Microscopic Colitis: Symptoms, Causes, Treatment

  https://resources.healthgrades.com/right-care/digestive-health/microscopic-colitis

  These symptoms may relapse and return frequently. Sometimes, the symptoms disappear and never come back. See your doctor if they persist. […] Some home remedies may make symptoms of microscopic colitis go away. They include drinking lots of water, consuming more easy-to-digest foods, reducing your fiber intake, cooking vegetables properly before eating them, eating more small meals and fewer large meals, avoiding high sugar or high sorbitol drinks, avoiding alcohol and caffeine, avoiding smoking, and discontinuing use of possible trigger medications. […] Your doctor may also recommend corticosteroids, such as budesonide (Pulmicort), to reduce inflammation; bulk-forming laxatives, such as psyllium (Metamucil), to make stool softer and easier to pass; immunosuppressants, such as TNF inhibitors (adalimumab, infliximab), to reduce atypical immune activity; and anti-diarrheal medicines, such as loperamide (Imodium), to reduce the number of bowel movements and make your stool less watery.

• #64

  https://link.springer.com/article/10.1007/s40266-023-01094-6

  All patients diagnosed with microscopic colitis should be recommended to stop smoking and any culprit medication should be discontinued. […] Although the current treatment options for microscopic colitis are affiliated with limitations, the management of microscopic colitis aims to resolve symptoms and, in this way, improve the quality of life of these patients. […] Nevertheless, even if a standard treatment regimen with budesonide (9 mg daily for 68 weeks) is usually prescribed, it is still unclear as to how long patients with microscopic colitis on the alternative treatment options should be treated, or if any prophylactic therapy exists. […] Finally, as microscopic colitis—a chronic disease with recurrent non-bloody, secretory diarrhea—can be a disabling life experience with impacts on every aspect of patients’ lives, including urgency and often unpredictable fecal incontinence, patients with symptoms should be offered regular follow-ups, and all elderly individuals with microscopic colitis should have easy access to a gastroenterologist in case of flaring disease.

• #65 UNC Researchers Reveal Prevalence of Persistent Symptoms in Patients with Microscopic Colitis | Newsroom

  https://news.unchealthcare.org/2023/12/unc-researchers-reveal-prevalence-of-colonoscopy-miscommunication-with-microscopic-colitis-patients/

  We thought it was important to better understand the burden of symptoms among those patients with microscopic colitis within the context of all patients undergoing colonoscopy to evaluate diarrhea, Redd said. […] These results highlight how clear communication is needed to address next steps after a diagnosis of the chronic disease. […] Identifying and addressing gaps in the communication of diagnostic results is an important area for future research. […] The first line therapy recommended for microscopic colitis is budesonide. However, findings show 46% of cases received that kind of treatment. […] In addition, many cases continued to experience ongoing loose stools, urgency, and fecal incontinence at one year, providing further evidence that patients should be offered follow-up appointments to assess how they are responding to treatment.

• #66 Prevalence, Pathogenesis, Diagnosis, and Management of Microscopic Colitis

  https://www.gutnliver.org/journal/view.html?volume=12&number=3&spage=227

  MC is a chronic condition impacting quality of life resulting in chronic diarrhea, intermittent remission and relapses. However, once diagnosed, most cases of MC can be treated successfully with medication and improvement in quality of life. There are multiple challenges in the diagnosis and management of MC, including finding an optimal long term maintenance strategy for treatment, given that recurrence is common. There is also a need for better histologic criteria to define disease activity and response, and perhaps to help predict an individual patients clinical course. These criteria would also serve as a meaningful guide for treatment algorithms and endpoints for clinical trials.

• #67 Microscopic colitis – IBD Clinic

  https://ibdclinic.ca/what-is-ibd/microscopic-colitis/

  While more drug studies have been undertaken in Collagenous Colitis than Lymphocytic Colitis, it is generally felt there is no need to treat these conditions differently. […] For people with mild Microscopic Colitis, antidiarrheal drugs, such as loperamide (Imodium) or diphenoxylate (Lomotil), can be sufficient. […] For people with more severe Microscopic Colitis, the steroid drug budesonide (Entocort) currently appears to be the most effective treatment. […] There is only limited evidence on foods that may affect people with Microscopic Colitis. […] It may also help to reduce your intake of caffeine and artificial sugars as they are known to draw fluid into the bowel that may aggravate diarrhea. […] The outlook for people with Microscopic Colitis is generally good. Four out of five can expect to be fully recovered within three years, with some even recovering without treatment.

• #68 Microscopic Colitis: Dr. Falk Pharma international

  https://drfalkpharma.com/en/indications/microscopic-colitis/

  The disease can severely impact patients’ quality of life due to the symptoms described here. […] The process of collecting a patient’s complete medical history includes asking the patient about his or her prior medical history as well as current symptoms, how long they last, and how severe they are. […] The most important test for microscopic colitis is a colonoscopy. […] Targeted medications are available to treat microscopic colitis. […] The goal of this treatment is to alleviate the symptoms of the disease, or even to eliminate them entirely, so that patients experience a better quality of life for a long time. […] With microscopic colitis, is not necessary to switch to a special diet. […] Smoking is known to have a negative impact on the course of the disease. […] Because microscopic colitis is not a life-threatening disease, it usually has a benign outcome. […] However, if left untreated, about half of all patients will experience chronic or recurring diarrhea, which can massively impact their quality of life. […] Microscopic colitis does not increase the risk of developing colorectal cancer according to the current scientific knowledge.

• #69 Microscopic Colitis | All you need to know | Gastro Health

  https://gastrohealth.com/news/patient-care/microscopic-colitis

  There is no evidence that microscopic colitis leads to an increase risk of colon cancer, as with ulcerative colitis. […] Management of microscopic colitis includes lifestyle changes aimed at reducing the diarrhea and discontinuing drugs like Nsaids and PPis. […] In many cases, treatment with antidiarrheal medications is necessary. Loperamide, Bismuth (Pepto Bismol), bulking agents like psyllium, or bile acid binding resins like cholestyramine are commonly used in the treatment of microscopic colitis. […] In more severe cases of diarrhea, corticosteroids can be used as treatment. Corticosteroids are medications that decrease inflammation and reduce the activity of the immune system. […] Therefore, this is the treatment of choice. […] Microscopic colitis is a chronic condition with symptoms that may come and go intermittently and cannot be diagnosed with blood tests or stool studies. […] In order to diagnose microscopic colitis, a physician must obtain a biopsy from the colon. […] In most cases, it can be easily treated and symptoms managed so patients can function normally.

• #70 Microscopic Colitis: Symptoms, Causes, Treatment

  https://resources.healthgrades.com/right-care/digestive-health/microscopic-colitis

  In many cases, microscopic colitis goes away with treatment. However, it may persist for months or even years. For the best outcome, follow your doctor’s treatment plan. […] You may be able to treat microscopic colitis at home. Try drinking lots of water and consuming more easy-to-digest foods. Also, try avoiding alcohol, caffeine, and high sugar drinks. […] Be sure to seek medical treatment if your symptoms persist.

• #71 Microscopic colitis – Symptoms, diagnosis and treatment | BMJ Best Practice US

  https://bestpractice.bmj.com/topics/en-us/3000315

  Microscopic colitis typically presents in people 50 years with chronic, nonbloody, watery diarrhea and is more common in women than in men. Other common symptoms include fecal urgency, fecal incontinence, and nocturnal stools. Symptoms can lead to a significantly impaired quality of life. […] Treatment aims to achieve clinical remission (3 stools per day and 1 watery stool per day) and improve quality of life. Drug choice depends on the severity and extent of disease and includes antidiarrheals, bismuth subsalicylate, oral budesonide, bile acid sequestrants, and immunosuppressants or biologic agents. All patients should additionally have modification of contributing factors, including diet changes if appropriate, avoiding/withdrawing culprit medications, and encouraging cigarette smokers to cease. […] Despite high rates of response to medical treatment, the relapse rate after discontinuation is 60% to 80% of patients with variable time to relapse. In patients with recurrent disease, consider re-treatment with prior therapies or with biologics for patients with severe refractory symptoms.

• #72 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Use this nursing care plan and management guide to provide care for patients with inflammatory bowel disease (IBD). Enhance your understanding of nursing assessment, interventions, goals, and nursing diagnosis, all specifically tailored to address the unique needs of individuals with IBD. […] Nursing care management of clients with inflammatory bowel diseases (IBD) includes control of diarrhea and promoting optimal bowel function; minimizing or preventing complications; promoting optimal nutrition, and providing information about the disease process and treatment needs. […] The following are the nursing priorities for patients with inflammatory bowel disease (IBD): Manage and reduce inflammation in the gastrointestinal tract. Alleviate symptoms such as abdominal pain, diarrhea, and rectal bleeding. Monitor disease activity and assess response to treatment. Prevent and manage complications, such as intestinal strictures or fistulas. Provide nutritional support and guidance to manage nutritional deficiencies. Administer appropriate medications to control inflammation and suppress the immune response. Educate patients on self-care measures and lifestyle modifications to manage symptoms. Offer support for emotional well-being and address the psychosocial impact of living with IBD.

• #73 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Goals and expected outcomes may include: The client will report a reduction in the frequency of stools and return to more normal stool consistency. The client will identify/avoid contributing factors. The client will maintain adequate fluid volume as evidenced by moist mucous membranes, good skin turgor, and capillary refill; stable vital signs; balanced IO with the urine of normal concentration/amount. The client will demonstrate behaviors to monitor and correct deficits, as indicated when the condition is chronic. The client will appear relaxed and report anxiety reduced to a manageable level. The client will verbalize awareness of feelings of anxiety and healthy ways to deal with them. The client will identify healthy ways to deal with and express anxiety. The client will use the support system effectively. The client will report pain is relieved/controlled. The client will appear relaxed and able to sleep/rest appropriately. The client will assess the current situation accurately. The client will identify ineffective coping behaviors and consequences. The client will acknowledge their own coping abilities. The client will demonstrate necessary lifestyle changes to limit/prevent recurrent episodes. The client will demonstrate stable weight or progressive gain toward the goal with normalization of laboratory values and the absence of signs of malnutrition. The client will verbalize understanding of disease processes, and possible complications. The client will identify stressful situations and specific action(s) to deal with them. The client will verbalize understanding of the therapeutic regimen. The client will participate in the treatment regimen. The client will initiate necessary lifestyle changes.

• #74 Partners in Care | Microscopic colitis treatment at Digestive Health

  https://partnersincare.health/conditions/microscopic-colitis

  Patients are cared for by a dedicated multidisciplinary care team, meaning you will benefit from the expertise of multiple specialists across a variety of disciplines. […] Our board-certified and fellowship-trained gastroenterologists have extensive experience with microscopic colitis and work alongside a team of digestive health experts, including colorectal surgeons, gastrointestinal-specialized dietitians, clinical social workers, physician assistants, nurses, advanced practice providers, and more, providing unparalleled care for patients every step of the way. […] We are committed to communicating and coordinating your care with referring physicians and other partners in the community to ensure that we are providing you with comprehensive, whole-person care.

• #75 10 Inflammatory Bowel Disease (IBD) Nursing Care Plans – Nurseslabs

  https://nurseslabs.com/inflammatory-bowel-disease-nursing-care-plans/

  Use this nursing care plan and management guide to provide care for patients with inflammatory bowel disease (IBD). Enhance your understanding of nursing assessment, interventions, goals, and nursing diagnosis, all specifically tailored to address the unique needs of individuals with IBD. […] Nursing care management of clients with inflammatory bowel diseases (IBD) includes control of diarrhea and promoting optimal bowel function; minimizing or preventing complications; promoting optimal nutrition, and providing information about the disease process and treatment needs. […] The following are the nursing priorities for patients with inflammatory bowel disease (IBD): Manage and reduce inflammation in the gastrointestinal tract. Alleviate symptoms such as abdominal pain, diarrhea, and rectal bleeding. Monitor disease activity and assess response to treatment. Prevent and manage complications, such as intestinal strictures or fistulas. Provide nutritional support and guidance to manage nutritional deficiencies. Administer appropriate medications to control inflammation and suppress the immune response. Educate patients on self-care measures and lifestyle modifications to manage symptoms. Offer support for emotional well-being and address the psychosocial impact of living with IBD.

• #76 Partners in Care | Microscopic colitis treatment at Digestive Health

  https://partnersincare.health/conditions/microscopic-colitis

  Patients are cared for by a dedicated multidisciplinary care team, meaning you will benefit from the expertise of multiple specialists across a variety of disciplines. […] Our board-certified and fellowship-trained gastroenterologists have extensive experience with microscopic colitis and work alongside a team of digestive health experts, including colorectal surgeons, gastrointestinal-specialized dietitians, clinical social workers, physician assistants, nurses, advanced practice providers, and more, providing unparalleled care for patients every step of the way. […] We are committed to communicating and coordinating your care with referring physicians and other partners in the community to ensure that we are providing you with comprehensive, whole-person care.

Zobacz więcej